129 related articles for article (PubMed ID: 25425056)
1. Antinociceptive properties of esculetin in non-inflammatory and inflammatory models of pain in rats.
Rzodkiewicz P; Gasinska E; Maslinski S; Bujalska-Zadrozny M
Clin Exp Pharmacol Physiol; 2015 Feb; 42(2):213-9. PubMed ID: 25425056
[TBL] [Abstract][Full Text] [Related]
2. Differential effect of zileuton, a 5-lipoxygenase inhibitor, against nociceptive paradigms in mice and rats.
Singh VP; Patil CS; Kulkarni SK
Pharmacol Biochem Behav; 2005 Jul; 81(3):433-9. PubMed ID: 15935457
[TBL] [Abstract][Full Text] [Related]
3. CJ-13610, an orally active inhibitor of 5-lipoxygenase is efficacious in preclinical models of pain.
Cortes-Burgos LA; Zweifel BS; Settle SL; Pufahl RA; Anderson GD; Hardy MM; Weir DE; Hu G; Happa FA; Stewart Z; Muthian S; Graneto MJ; Masferrer JL
Eur J Pharmacol; 2009 Sep; 617(1-3):59-67. PubMed ID: 19580807
[TBL] [Abstract][Full Text] [Related]
4. A rat air pouch model for evaluating the efficacy and selectivity of 5-lipoxygenase inhibitors.
Zweifel BS; Hardy MM; Anderson GD; Dufield DR; Pufahl RA; Masferrer JL
Eur J Pharmacol; 2008 Apr; 584(1):166-74. PubMed ID: 18295198
[TBL] [Abstract][Full Text] [Related]
5. Pre-clinical pharmacology of ICI D2138, a potent orally-active non-redox inhibitor of 5-lipoxygenase.
McMillan RM; Spruce KE; Crawley GC; Walker ER; Foster SJ
Br J Pharmacol; 1992 Dec; 107(4):1042-7. PubMed ID: 1334748
[TBL] [Abstract][Full Text] [Related]
6. Antinociceptive and antihyperalgesic effects of tapentadol in animal models of inflammatory pain.
Schiene K; De Vry J; Tzschentke TM
J Pharmacol Exp Ther; 2011 Nov; 339(2):537-44. PubMed ID: 21816956
[TBL] [Abstract][Full Text] [Related]
7. Naja sputatrix Venom Preconditioning Attenuates Neuroinflammation in a Rat Model of Surgical Brain Injury via PLA2/5-LOX/LTB4 Cascade Activation.
Wang Y; Sherchan P; Huang L; Akyol O; McBride DW; Zhang JH
Sci Rep; 2017 Jul; 7(1):5466. PubMed ID: 28710425
[TBL] [Abstract][Full Text] [Related]
8. 5-lipoxygenase inhibitory activity of zileuton.
Carter GW; Young PR; Albert DH; Bouska J; Dyer R; Bell RL; Summers JB; Brooks DW
J Pharmacol Exp Ther; 1991 Mar; 256(3):929-37. PubMed ID: 1848634
[TBL] [Abstract][Full Text] [Related]
9. Esculetin reduces leukotriene B4 level in plasma of rats with adjuvant-induced arthritis.
Rzodkiewicz P; Gąsińska E; Gajewski M; Bujalska-Zadrożny M; Szukiewicz D; Maśliński S
Reumatologia; 2016; 54(4):161-164. PubMed ID: 27826169
[TBL] [Abstract][Full Text] [Related]
10. Pharmacology of PF-4191834, a novel, selective non-redox 5-lipoxygenase inhibitor effective in inflammation and pain.
Masferrer JL; Zweifel BS; Hardy M; Anderson GD; Dufield D; Cortes-Burgos L; Pufahl RA; Graneto M
J Pharmacol Exp Ther; 2010 Jul; 334(1):294-301. PubMed ID: 20378715
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of 5-lipoxygenase in rat and human esophageal adenocarcinoma and inhibitory effects of zileuton and celecoxib on carcinogenesis.
Chen X; Wang S; Wu N; Sood S; Wang P; Jin Z; Beer DG; Giordano TJ; Lin Y; Shih WC; Lubet RA; Yang CS
Clin Cancer Res; 2004 Oct; 10(19):6703-9. PubMed ID: 15475461
[TBL] [Abstract][Full Text] [Related]
12. The analgesic effect of crotoxin on neuropathic pain is mediated by central muscarinic receptors and 5-lipoxygenase-derived mediators.
Nogueira-Neto Fde S; Amorim RL; Brigatte P; Picolo G; Ferreira WA; Gutierrez VP; Conceição IM; Della-Casa MS; Takahira RK; Nicoletti JL; Cury Y
Pharmacol Biochem Behav; 2008 Dec; 91(2):252-60. PubMed ID: 18778727
[TBL] [Abstract][Full Text] [Related]
13. Reduction of renal ischemia-reperfusion injury in 5-lipoxygenase knockout mice and by the 5-lipoxygenase inhibitor zileuton.
Patel NS; Cuzzocrea S; Chatterjee PK; Di Paola R; Sautebin L; Britti D; Thiemermann C
Mol Pharmacol; 2004 Aug; 66(2):220-7. PubMed ID: 15266012
[TBL] [Abstract][Full Text] [Related]
14. Oral administration of Ginkgo biloba extract, EGb-761 inhibits thermal hyperalgesia in rodent models of inflammatory and post-surgical pain.
Biddlestone L; Corbett AD; Dolan S
Br J Pharmacol; 2007 May; 151(2):285-91. PubMed ID: 17375081
[TBL] [Abstract][Full Text] [Related]
15. Phorbol ester-induced dermal inflammation in mice: evaluation of inhibitors of 5-lipoxygenase and antagonists of leukotriene B4 receptor.
Rao TS; Yu SS; Djuric SW; Isakson PC
J Lipid Mediat Cell Signal; 1994 Sep; 10(3):213-28. PubMed ID: 7812673
[TBL] [Abstract][Full Text] [Related]
16. Bilobalide, a unique constituent of Ginkgo biloba, inhibits inflammatory pain in rats.
Goldie M; Dolan S
Behav Pharmacol; 2013 Aug; 24(4):298-306. PubMed ID: 23838965
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the antiinflammatory activity of a dual cyclooxygenase-2 selective/5-lipoxygenase inhibitor, RWJ 63556, in a canine model of inflammation.
Kirchner T; Argentieri DC; Barbone AG; Singer M; Steber M; Ansell J; Beers SA; Wachter MP; Wu W; Malloy E; Stewart A; Ritchie DM
J Pharmacol Exp Ther; 1997 Aug; 282(2):1094-101. PubMed ID: 9262379
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of 5-lipoxygenase and cyclooxygenase 2 in hamster and human oral cancer and chemopreventive effects of zileuton and celecoxib.
Li N; Sood S; Wang S; Fang M; Wang P; Sun Z; Yang CS; Chen X
Clin Cancer Res; 2005 Mar; 11(5):2089-96. PubMed ID: 15756036
[TBL] [Abstract][Full Text] [Related]
19. Zileuton alleviates acute cisplatin nephrotoxicity: Inhibition of lipoxygenase pathway favorably modulates the renal oxidative/inflammatory/caspase-3 axis.
Helmy MM; Hashim AA; Mouneir SM
Prostaglandins Other Lipid Mediat; 2018 Mar; 135():1-10. PubMed ID: 29355720
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of Leukotriene B4 Action Mitigates Intracerebral Hemorrhage-Associated Pathological Events in Mice.
Hijioka M; Anan J; Ishibashi H; Kurauchi Y; Hisatsune A; Seki T; Koga T; Yokomizo T; Shimizu T; Katsuki H
J Pharmacol Exp Ther; 2017 Mar; 360(3):399-408. PubMed ID: 28035009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
